Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biologic interventions in rheumatoid arthritis

J J Cush1, A F Kavanaugh

  • 1University of Texas Southwestern Medical Center, Rheumatic Diseases Division, Dallas 75235-8577, USA.

Rheumatic Diseases Clinics of North America
|August 1, 1995
PubMed
Summary

Advances in understanding rheumatoid arthritis and biotechnology enable new immune-specific therapies. This review explores current and future biopharmaceutical targets for treating rheumatoid arthritis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long term efficacy and safety of adalimumab plus methotrexate in patients with rheumatoid arthritis: ARMADA 4 year extended study.

Annals of the rheumatic diseases·2005
Same author

Laboratory monitoring of biologic therapies.

Clinical and experimental rheumatology·2005
Same author

Biological drug use: US perspectives on indications and monitoring.

Annals of the rheumatic diseases·2005
Same author

Unusual toxicities with TNF inhibition: heart failure and drug-induced lupus.

Clinical and experimental rheumatology·2004
Same author

Association between baseline radiographic damage and improvement in physical function after treatment of patients with rheumatoid arthritis.

Annals of the rheumatic diseases·2004
Same author

The role of interleukin-1 in bone resorption in rheumatoid arthritis.

Rheumatology (Oxford, England)·2004

Area of Science:

  • Immunology
  • Biotechnology
  • Pharmacology

Background:

  • Rheumatoid arthritis (RA) is a complex autoimmune disorder.
  • Understanding RA's immunopathogenesis has advanced significantly.
  • Biotechnology has enabled the development of targeted therapies.

Purpose of the Study:

  • To review current and potential biopharmaceutical targets for RA.
  • To discuss the utility of these agents in RA treatment.

Main Methods:

  • Literature review of immunopathogenesis and biopharmaceutical agents in RA.
  • Analysis of current and emerging therapeutic targets.

Main Results:

  • Biologic interventions are increasingly used for RA.
  • Numerous targets for biopharmaceutical agents exist.
  • These agents show promise in managing RA.

Conclusions:

  • Biopharmaceutical agents represent a key therapeutic strategy for RA.
  • Continued research into novel targets is crucial for improving RA outcomes.

Related Experiment Videos